Xerostomia Therapeutics Market Size, Strategies, Competitive Landscape, Trends & Factor Analysis, 2022–2028

コメント · 196 ビュー

The global dry mouth relief market size is expected to reach USD 3.12 Billion by 2028 at a CAGR of 4.4%, according to the latest report by Reports and Data.

The global Xerostomia Therapeutics market size is expected to reach USD 3.12 Billion by 2028 at a CAGR of 4.4%, according to the latest report by Reports and Data. Rising incidence of dry mouth owing to increased consumption of medications, as a side-effect of chemotherapy and radiotherapy, from nerve damage or dehydration, and conditions affecting salivary glands has been boosting demand for Xerostomia Therapeutics products and is a key factor expected to drive market revenue growth over the forecast period. Availability of wide range of products, increasing affordability, and growing awareness regarding the condition are some other key factors expected to fuel revenue growth of the market over the forecast period.

Dry mouth, also called Xerostomia, occurs when salivary glands produce insufficient amount of saliva to prevent drying of the mouth. Dry mouth can be uncomfortable and can be treated by over-the-counter saliva substitutes, mouthwash specifically designed for dry mouth, and regular water intake. Sugar-free chewing gums, toothpastes, patches, and oral rinses are widely available in the market for the treatment of dry mouth. Demand for these products has increased significantly over the recent past owing to increasing incidence of dry mouth in geriatric patients and as a side effect of diabetes, anemia, and hypertension, among others. Dry mouth can also be a side effect of muscle relaxant and sedatives.

Increasing burden of cancer has led to a rapid rise in administration of radiotherapy and chemotherapy to patients. These therapeutic approaches, such a radiation therapy to head and neck can damage salivary glands and this has increased incidence of dry mouth among cancer patients. This is expected to boost demand for Xerostomia Therapeutics products over the forecast period. In addition, increasing incidence of dry mouth among COVID-19 patients due to increasing consumption of medicines is also a growth driving factor. However, lack of awareness in developing and underdeveloped countries and ineffectiveness of these products to treat dry mouth over long term are expected to hamper market growth to a certain extent over the forecast period.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/266

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Some Key Highlights from the Report:

  • Mouthwash segment is expected to account for largest revenue share in the global market over the forecast period owing to increasing recommendation of mouthwash by doctors due to their anti-inflammatory and anti-bacterial properties.
  • E-commerce segment is expected to register fastest revenue CAGR over the forecast period owing to increasing penetration of e-commerce channels, rising preference for doorstep delivery, and availability of wide range of products on a single channel.
  • North America is expected to account for largest revenue share in the global market owing to increasing consumption and demand for Xerostomia Therapeutics products, rising geriatric population, increasing burden of cancer and other chronic illnesses, and availability of advanced products in the market.

  Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, and product service portfolio. The Xerostomia Therapeutics market is extremely competitive and consists of several key players at the regional and global levels. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in RD, partnerships, joint ventures, and collaborations to strengthen their market position and enhance their product portfolio.

Leading companies operating in the market are:

  • Mission Pharmacal Company
  • GlaxoSmithKline Plc
  • Prestige Consumer Healthcare Inc.
  • Colgate-Palmolive Company
  • Sanofi S.A., Mars
  • Incorporated
  • Bioxtra
  • Sunstar Group
  • Fresenius Medical Care AG Co. KGaA
  • Dr. Fresh Inc.
  • Xlear Inc.
  • Johnson Johnson Services Inc.
  • Oral BioTech LLC
  • TheraBreath
  • The 3M Company
  • Wisconsin Pharmacal Company LLC,
  • The Procter Gamble Company

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/266

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

  Xerostomia Therapeutics Market Segmentation:

Drug Type Outlook:

  • Over-the-counter
  • Prescribed

Product Type Outlook:

  • Mouthwash
  • Spray
  • Gel
  • Lozenges
  • Others

Application Outlook:

  • Pharmacies
  • E-commerce Channels
  • Supermarkets/Hypermarkets
  • Others

Regional Outlook:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of LATAM)
  • Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East Africa)

Some essential purposes of the Xerostomia Therapeutics market research report:

  • Vital Developments: Custom investigation provides critical improvements to the Xerostomia Therapeutics market, including RD, new item shipment, coordinated efforts, development rate, partnerships, joint efforts, and local development of rivals working in the market on a global scale and regional.
  • Market Characteristics: The report contains Xerostomia Therapeutics market highlights, income, limit, limit utilization rate, value, net, creation rate, generation, utilization, import, trade, supply, demand, cost, part of the industry in general, CAGR, and gross margin. Likewise, the market report offers an exhaustive investigation of the elements and their most recent patterns, along with Service market fragments and subsections.
  • Investigative Tools: This market report incorporates the accurately considered and evaluated information of the major established players and their extension into the Xerostomia Therapeutics market by methods. Systematic tools and methodologies, for example, Porter’s Five Powers Investigation, Possibilities Study, and numerous other statistical investigation methods have been used to analyze the development of the key players working in the Xerostomia Therapeutics market.
  • Convincingly, the Xerostomia Therapeutics report will give you an unmistakable perspective on every single market reality without the need to allude to some other research report or source of information. This report will provide all of you with the realities about the past, present, and eventual fate of the Xerostomia Therapeutics market.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/266

Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

Explore More Industry Research by Reports and Data:

Polycythemia Vera Market @ https://www.biospace.com/article/increase-in-polycythemia-incidence-is-expected-to-drive-industry-growth-in-polycythemia-vera-market/

Post-Surgical Pain Treatment Market @ https://www.biospace.com/article/post-surgical-pain-treatment-market-insights-competitive-scenario-of-the-industry-with-growth-prospect-2030/

Hunter Syndrome Market @ https://www.biospace.com/article/hunter-syndrome-market-showing-impressive-growth-by-size-share-top-companies-and-regional-forecast-to-2030/

Cerebral Infarction Treatment Market @ https://www.biospace.com/article/cerebral-infarction-treatment-market-research-report-on-growth-recent-trends-and-demand-by-top-key-vendors-and-forecast-to-2030/

  About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

コメント